Editas Medicine (EDIT) Change in Acquisitions & Divestments (2017 - 2025)

Editas Medicine (EDIT) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $40.0 million in Q3 2025.

• Quarterly Change in Acquisitions & Divestments fell 53.96% year-over-year to $40.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $170.5 million (down 48.11% YoY) and the FY2024 annual result came in at $257.2 million, down 0.89% from the prior year.
• Change in Acquisitions & Divestments retreated to $40.0 million in Q3 2025 per EDIT's latest filing, from $42.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $130.8 million in Q1 2021 and bottomed at $31.5 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $74.2 million (2021), against an average of $76.4 million.
• The widest annual swing landed in 2021, when Change in Acquisitions & Divestments soared 176.48%; it then tumbled 69.39% in 2024.
• Tracing EDIT's Change in Acquisitions & Divestments over 5 years: stood at $84.3 million in 2021, then fell by 6.91% to $78.5 million in 2022, then surged by 31.08% to $102.9 million in 2023, then plunged by 69.39% to $31.5 million in 2024, then increased by 27.03% to $40.0 million in 2025.
• Per Business Quant, the three latest EDIT Change in Acquisitions & Divestments figures stand at $40.0 million (Q3 2025), $42.5 million (Q2 2025), and $56.5 million (Q1 2025).

Peer Comparison